Skip to main content

AstraZeneca to Use BioWisdom Data-Mining Services

NEW YORK (GenomeWeb News) – AstraZeneca has selected BioWisdom to provide customized vocabulary and meta-data from its toxicological reports based on its development compounds, BioWisdom said today.

Under the agreement, BioWisdom will convert documents to machine-readable formats, and provide entity extraction and derivation, semantic normalization, mapping, and meta-data.

BioWisdom Chief Scientific Officer Julie Barnes said in a statement that the project "will enable AstraZeneca to harness value from both public and now private repositories of safety-related information."

Financial terms of the agreement were not released.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.